Gene expression relevant to abnormal cell differentiation and altered cell cycle in endometrial epithelial cells was investigated immunohistochemically in developing mouse uteri exposed neonatally to diethylstilbestrol (DES). Female CD-1 mice were given daily SC injections of 2 &mu;g of DES in corn oil or were given corn oil alone (control) at 1-5 days of age and euthanatized at 5, 6, 7, 8, 15, and 22 days of age. The endometrial epithelial cells of DES-treated mice at 5-8 days of age showed enhanced staining intensity for the estrogen receptor alpha (ER&alpha;), whereas the stromal cells showed decreased staining reaction; the epithelial cells showed that the protein encoded by the c-fos proto-oncogene, which plays a key role in regulating diverse estrogen-related cellular differentiation patterns, was enhanced. These cells also showed increased expression of lactoferrin, a sensitive protein marker of estrogen exposure, although the staining intensity decreased after exposure ended. The stain for p21 protein, a mitotic inhibitor which suppresses cyclindependent kinase activity, showed frequent positively stained cells in DES-treated mice at 5-15 days of age, whereas no accumulation of p53 protein of either wild or mutant type was detected immunohistochemically in these cells. These results indicate that suppressed cell cycle activity of endometrial epithelial cells and abnormal estrogen-related differentiation at the developmental stage following neonatal DES exposure may be caused, in part, by transient altered expression of ER&alpha; and expression of the p21 gene, which appears to be induced by a p53 -independent mechanism.
INTRODUCTION
The developing female genital tract shows ovary-independent growth but is very sensitive to the effects of estrogens (8, 10, 17, 18, 19, 33) . In fact, the differentiation of this tissue is easily disrupted by estrogens, which can alter the expression of important genes responsible for proliferation and differentiation of target cells at this stage (3, 31, 35) . The genetic and/or epigenetic insult to this tissue caused by exogenous estrogens results in irreversible alterations in the target cells, which lead to permanent reproductive dysfunction and an increased risk of tumor formation (11, 22, 24) . The mechanisms of these abnormalities remain unknown, but early changes that occur in the target tissues following estrogen exposure may be very important to understanding the pathogenesis of these abnormalities and tumor development.
In our previous study (34) , we demonstrated that endometrial epithelial cells of CD-1 mice exposed to diethylstilbestrol (DES) at 1-5 days of age had early abnormal differentiation in morphology and transient cell cycle suppression, as shown by bromodeoxyuridine (BrdU) labeling index, at 5-8 days of age. Cell cycle suppression is a novel finding of DES exposure in neonatal female genital tissues and is suspected to be one of the causative factors of subsequent abnormalities, when genes that control cell growth and differentiation lose the unique timing of their expression for normal development of the uterus.
The effect of p21 protein on growth arrest without p53 activation was recently reported in mouse embryogenesis (27) . A similar mechanism of cell cycle arrest by p21 protein was demonstrated in terminally differentiated cells in a variety of normal tissues, including the tips of the gastrointestinal mucosa (5, 6) . Based on these data, we propose that the cell cycle suppression we observed in abnormally differentiating endometrial epithelial cells at 5-8 days in mice neonatally exposed to DES in our previous study (34) may be secondary to p21 protein expression. Induction of p21 protein and subsequent cell cycle arrest are also known to occur in a p53-dependent manner in response to DNA damage in target cells (23) . Therefore, a combination analysis for p21 and p53 protein was considered essential to evaluate the mechanism of cell cycle suppression observed in endometrial epithelial cells in our previous study (34) .
Recently, investigators have reported that expression of the c fos proto-oncogene is increased during differentiation in several systems (12) and that this gene is involved in estrogen regulation of uterine epithelial cell proliferation in immature (3) and adult rodents (7, 26, 31, 35) . Based on these findings, we propose the possibility that the early abnormal differentiation of endometrial epithelial cells exposed neonatally to DES observed in our previous study (34) is the consequence of c-fos gene expression mediated by the estrogen receptor alpha (ERa). a Diluted normal serum was used as the negative control in place of each primary antibody. n Deparaffinized thin sections on glass slides placed in a container filled with 10 mM citrate buffer, pH 6.0, were processed by 2 cycles of 50-minute heating in a 800watt microwave oven and cooled down to room temperature for 45 minutes.
Also, abundant intracytoplasmic secretory granules were observed in these cells by electron microscopy (34) . We speculated that these granules represent lactoferrin, which is a known marker of estrogenic stimulation in endometrial epithelial cells (28) .
Based on our earlier observations that DES induced abnormal uterine endometrial cell differentiation and cell cycle suppression in CD-1 mice, the present study was designed to investigate whether endometrial epithe-lial cells exposed neonatally to DES demonstrate characteristic alterations in estrogen receptors and in c-fos and lactoferrin genes that might be associated with early abnormal differentiation in the developing uterus; whether the transient cell cycle suppression previously reported is associated with expression of p21 gene, an inhibitor of cell mitosis; and whether the expression of p21 protein is induced by a p53-dependent or -independent pathway. Staining intensity (bar graph) in epithelial and stromal cells and the incidence (%) of positive nuclei stained with ERa antibody in the epithelium (line graph). Note the staining intensity (0 = negative, 1 = weak, 2 = moderate, 3 = strong, 4 = intense, and 5 = very intense) and the number of positive nuclei are enhanced in the epithelium of DES-treated mice, in contrast to the decreased staining intensity in stromal cells of this group. The data are mean ± SD of 4 animals/group. *-p < 0.01; *p < 0.05. X450. At 5 days of age, the staining intensity of nuclear ERa in endometrial epithelial cells of a DES treated mouse (b) is enhanced compared with the control (a), in contrast to less staining intensity in stromal cells. The arrow indicates weak expression of the estrogen receptor in control endometrial epithelial cells. At 8 days of age, enhanced staining intensity for ERa is still observed in endometrial epithelial cells in a DES-treated mouse (d); the intensity in control epithelial cells (c) is increased as compared with day 5 controls, especially at the primitive endometrial gland (arrow). At 15 days of age, almost all cells in the epithelial and stromal layers show strong staining intensity in both control (e) and DES-treated (f) uteri.
MATERIALS AND METHODS
Animals and Treatment. Pregnant outbred female CD-1 mice near term were obtained from the breeding colony at the National Institute of Environmental Health Sciences (NIEHS), were housed individually in cages under controlled temperature (21-22°C) and lighting (a 12-hour light/dark schedule), and were maintained with NIH 31 1 (National Institutes of Health, Bethesda MD) mouse chow and water ad libitum. At delivery, male offspring were removed, and the litters were adjusted to 8 female pups/dam. Female pups were given daily subcutaneous (SC) injections of 2 [Lg of DES (Sigma Chemical Co, St Louis, MO) in corn oil (Sigma Chemical Co) or were given corn oil alone (control) at 1-5 days of age; 4 animals/group were sacrificed at 5, 6, 7, 8, 15, and 22 days of age. All animal procedures complied with NIEHS animal care and use guidelines.
Immunohistochemistry. The reproductive tract was quickly removed and immersed in cold 10% neutral buffered formalin. The middle portion of the uterine horn was fixed overnight, transferred to 70% ethanol, and embed-ded in paraffin. Thin sections (5 f.1m) were mounted on poly-L-lysine-coated glass slides and stained immunohistochemically with the antibodies listed in Table 1 . Immunoreactive complexes were detected by the avidin-biotin affinity system (Vectastain ABC or Elite ABC kits, Vector Laboratories, Burlingame, CA) and visualized with 3,3'-diaminobenzidine tetrahydrochloride (Sigma Chemical Co) as the chromogen. The sections were counterstained with Mayer's hematoxylin (Poly Scientific Research and Development Corp, Bay Shore, NY) and observed under light microscopy.
The staining intensity for ERa, c-fos proto-oncogene protein, and lactoferrin was quantitatively estimated as 0 -negative, 1 = weak, 2 = moderate, 3 = strong, 4 = intense, and 5 = very intense. These categories are fundamentally the same as those used in previous studies (7, 32) . The labeling indices (%) of ERa and p21 protein in endometrial epithelial cells were determined by counting the positive nuclei in all luminal epithelial cells (201-654 cells) in 1 cross-section of the middle portion of the uterine horn from each animal. The p53 protein was not quantified in endometrial epithelial cells because there was no positive reaction. In contrast, a strong staining intensity for p53 was observed in mammary tumor cells, which served as a positive control.
Statistical Analysis. Significant differences in the data for p21 protein between control and treated animals were evaluated by Student's t-test. The data on ERa, c-fos protein, and lactoferrin were analyzed by Wilcoxon's rank sum test (2-tailed).
RESULTS
The immunohistochemical investigations in the present study showed distinct tissue-specific patterns in the localization of the following proteins in formalin-fixed, paraffin-embedded uterine tissues of the control and DEStreated mice at 5-22 days of age. These patterns were clearly altered in the uteri of mice treated neonatally with DES.
ERa
Immunodetectable ERa protein was observed in endometrial epithelial cells, endometrial stromal cells, and myometrial cells in control and DES-treated mice at 5-22 days of age. There were distinctive, tissue-specific exposure patterns for ERa protein, the appearance of which were dependent upon neonatal DES exposure (Figures 1   and 2 ).
The staining intensity of ERa in the nuclei of endometrial epithelial cells in control mice at 5 days of age was very weak, and the appearance was heterogeneous, observed as a few positive cells among the majority of negative cells (Figures la and 2a ). The number of positive cells in the luminal epithelium and their staining intensity increased gradually with age in control mice. A strong immunoreaction was first observed in the nuclei of epithelial cells of the premature endometrial glands at 8 days of age ( Figure 2c ). In DES-treated mice, luminal epithelial cells exhibited moderate to strong staining for ERa in their nuclei at 5 days of age ( Figure 2b ). The enhanced staining intensity in DES-treated mice, compared with that of the control mice at the same age, persisted up to 8 days of age (Figure 2d ). At 15 and 22 days of age, all nuclei of luminal and glandular endometrial epithelial cells stained very intensely with ERa antibody in both control (Figure 2e ) and DES-treated (Figure 2f) groups.
The immunoexpression of ERa in the nuclei of stromal (Figures lb and 2 ) and myometrial cells was consistently very intense in control mice at 5-22 days of age. In DEStreated mice, ERa staining intensity was less than that of the controls at 5 days of age but gradually increased over 5-8 days of age (Figure 2b, d) . At 15 and 22 days of age, almost all nuclei of stromal cells showed very intense staining (Figure 2e , f).
c-Fos Proto-Oncogene Protein
The protein encoded by the c-fos proto-oncogene occurred in uterine epithelium, stroma, and myometrium of control and DES-treated mice at 5-22 days of age, but the staining intensity in these cells was consistently very weak except for the epithelium of DES-treated mice ( ithelial cells showed clearly increased staining intensity at 5 days of age as compared with the controls. This enhancement persisted up to 8 days of age (Figure 4 ) but decreased to control levels by 22 days of age. The immunoproducts of the c-fos proto-oncogene protein in endometrial epithelial cells of DES-treated mice at 5-8 days of age were located in the nuclei and in the apical perinuclear cytoplasm.
Lactoferrin
The immunoproduct of lactoferrin was detected in the cytoplasm of endometrial epithelial cells and in the secretory material in the lumen of endometrial glands of both control and DES-treated mice (Figures 5 and 6 ). In control mice, the uteri did not show obvious expression of this protein at 5-8 days of age (Figure 6a ) but showed weak to moderate expression in the cytoplasm of the luminal and glandular epithelial cells at 15 and 22 days of age; strong immunoexpression was seen in secretory material in the lumen of endometrial glands (Figure 6c ). In DES-treated mice, immunoexpression of lactoferrin was clearly observed in the apical cytoplasm of luminal epithelial cells at 5-8 days of age (Figure 6b ), but the staining intensity decreased after DES exposure ceased. In contrast, the epithelial cells of DES-treated mice at 22 days of age showed weak staining intensity as compared with those of the controls (Figure 6d ). 
p21 Protein
The reaction product of p21 protein was observed in the nuclei of endometrial epithelial cells in both control and DES-treated mice (Figures 7 and 8) . However, the number of positive nuclear cells was very low in the uteri of control mice and restricted to the luminal epithelium (Figure 8a ). In DES-treated mice, the number of positive nuclei for p21 protein was significantly increased at 5-22 days of age as compared with the controls, with a peak at 8 days of age (Figure 7 ). The positive cells in DES-treated uteri were observed in both the luminal and glandular endometrial epithelium but most frequently at the site of invaginated luminal epithelium and in endometrial glands (Figure 8b, d ).
p53 Protein Immunohistochemical investigation of the p53-encoded protein including wild and mutant types demonstrated no positive cells in the uteri of either the control and DES-treated mice at 5-22 days of age.
DISCUSSION
These immunohistochemical investigations demonstrate a causal relationship between cell cycle suppression of endometrial epithelial cells and their early abnormal differentiation in developing mouse uteri exposed neonatally to DES. The data are also suggestive of a possible important role of the upregulation of ERa in uterine epithelial cells in the pathogenesis of these abnormalities and the abnormal overexpression of genes that may be regulated by estrogens.
The time course change of ERa immunoexpression in the nuclei of endometrial epithelial cells of control mice was similar to that observed previously; the receptor is absent or at low levels during the first week of neonatal life, with a heterogeneous appearance (15, 33) , then the FIGURE 6.-Immunohistochemical staining of lactoferrin in endometrial epithelial cells from control (a) and DES-treated (b) mice at 5 days of age and in endometrial glands from the control (c) and DES-treated (d) mice at 22 days of age. X450. In DES-treated mice, immunoreaction of lactoferrin in the cytoplasm is clearly enhanced in endometrial epithelial cells at 5 days of age (b) but is decreased in endometrial glandular cells at 22 days of age (d) compared to the corresponding control. number and intensity of positive epithelial cells gradually increase with age until almost 100% of the nuclei of uterine epithelil cells show nuclear expression of the receptor by 15 days of age (32) . In DES-treated mice, immunostaining for ERa was inverse; at 5-8 days of age, upregulation of ERa in epithelial cells and downregulation of ERa in stromal and myometrial cells were observed. The level of estrogen receptors in endometrial epithelial cells of neonatal mouse uterus is readily enhanced by estrogenic stimulation (29, 30, 33) , but the role of ERa in the mechanisms of reversible and irreversible abnormalities by DES in female genital tracts is not well understood (2, 11, 18, 22) . The alterations of ERa in epithelial cells were coincidentally observed with overexpression of cfoes proto-oncogene protein and lactoferrin, which are reported to be regulated by estrogens (7, 13, 31, 35) . Therefore, the concomitant expression of the genes responsible for ERa, c-fos proto-oncogene protein, and lactoferrin in DES-treated mice at 5-8 days of age was strongly suggestive of their relationship and their roles in abnormal tissue growth of the developing mouse uterus exposed neonatally to DES (36). The prolonged expression of ERa for 3 days after treatment stopped is indicative of a unique profile of this receptor protein in the endometrial cells of the developing mouse uterus, given that the level of ERa in the adult rodent uterus is reduced in 5 days following repeated exposures to high doses of estrogens (16) .
The intense and constant immunoexpression of ERa was observed in the stromal and myometrial cells of con-trol mice at 5-22 days of age, and this result was similar to those previously observed (9, 15, 29, 32) . In contrast, the levels of ERa in stromal and myometrial cells of DES-treated mice were obviously depressed at 5-8 days of age. The effects of estrogenic chemicals on the ERa in mesenchymal components of developing female genital tract have not been well studied as compared with the effects on the epithelium (29, 33) , but the marked suppression of ERa in the stromal and myometrial cells in DES-treated mice in this study might be responsible for the disorganization of the stromal and myometrial layers seen in the DES-treated rodent uterus (4) . The results of immunohistochemistry for the ERa showed that neonatal DES exposure enhanced the expression of ERa in endometrial epithelial cells but suppressed expression in stromal and myometrial cells in the developing mouse uteri at 5-8 days of age.
Immunohistochemistry for c-fos proto-oncogene protein demonstrated clear evidence of overexpression in epithelial cells in DES-treated mice at 5-8 days of age in contrast to negligible immunoreaction in epithelial cells of control mice. Recent studies have demonstrated that steroid hormones regulate cell function, growth, and differentiation by stimulating the local biosynthesis of peptide growth factors and proteins encoded by the AP-1 gene family that act in an autocrine or paracrine fashion. Some estrogen-regulated genes such as proto-oncogenes (3, 12, 13, 35) and growth factor peptides and their cognate receptors (7, 14, 19, 21) have been proposed as being responsible for these mechanisms in normal and im- planted uteri of adult rodents. In the developing mouse uterus whose growth control mechanisms are not well understood, epidermal growth factor (EGF; 19) , EGF receptor (7) , and c-fos proto-oncogene (7, 13, 35) are considered to be major factors. However, Falck and Forsberg (7) reported that the upregulation of EGF by neonatal DES exposure is primarily observed in the endometrial stromal cells. In contrast, the level and distribution of cfos proto-oncogene protein was clearly enhanced in epithelial cells. Therefore, it is hypothesized that the c-fos proto-oncogene might be one of the major factors in the mechanism of abnormal growth and differentiation in endometrial epithelium following neonatal DES exposure. The proto-oncogenes are reported to play a direct role in estrogen-stimulated cell growth (35) , and the transcriptional activity of c-fos proto-oncogene is a primary response of estrogens in the rodent uterus (31) , which regulate cell growth, differentiation, and development of endometrial epithelial cells (7) . The endometrial epithelial cells showing clear expression of c-fos proto-oncogene protein also had abnormal early differentiation in morphology in a previous study (34) . Therefore, the results are suggestive of a causal relationship between the expression c fos proto-oncogene protein and abnormal differentiation of endometrial epithelial cells in developing mouse uteri exposed neonatally to DES. In the present study, the localization of c-fos proto-oncogene protein was mostly demonstrated in the epithelial component. Papa et al. (26) reported that the c-fos proto-oncogene located in the uterine epithelial cells of adult rats was activated by 17p-estradiol, but other investigators reported that expression of fos genes was also enhanced in all major cell types in immature rat (3) and hamster (35) uteri. Thus, further investigations are needed to determine the localization and role of this gene product in abnormal tissue growth in developing female genital tracts following exposure to estrogens.
Immunoexpression of lactoferrin was observed in the luminal epithelial cells of DES-treated mice at 5-8 days of age, with decreasing intensity after exposure ceased, and in luminal and glandular epithelia of both DES-treated and control uteri at 15 and 22 days of age. Lactoferrin is the major estrogen-inducible protein of mouse uterine secretion (28) . This protein is a very sensitive marker of estrogenic stimulation (23, 33) , and its expression is mediated by the estrogen receptor (5) . Because lactoferrin immunoreaction is very low in the genital tract of control neonatal mice at 3-8 days of age (23), secretion of this protein by endometrial luminal epithelial cells of DEStreated mice is evidence of early abnormal differentiation in these cells. The enhanced secretion of lactoferrin in luminal epithelial cells of DES-treated mice may represent the abundant secretory granules observed with an electron microscope in the apical cytoplasm of the luminal epithelial cells of DES-treated mice at 5 and 8 days of age (34) . The results are suggestive of unscheduled differentiation of endometrial epithelial cells in the immature mouse uterus induced by neonatal DES exposure. Immunoreactivity of p21 protein was observed in the luminal epithelial cells at 5-8 days of age and in glandular cells or invaginated luminal epithelial cells at 15 and 22 days of age in DES-treated mice. The accumulation of p21 protein, which inhibits cell mitosis by inhibition of cyclin-dependent kinase activity in these cells, is associated with cell cycle suppression of luminal epithelial cells in DES-treated mice at 5-8 days of age (34) .
The expression of this protein is reported to be induced by a p53-dependent mechanism following DNA damage or by a p53-independent mechanism that is usually observed in terminally differentiated cells (25) . Although positive immunohistochemical staining for p53 wild-type protein may result in a false-negative result, no accumulation of p53 protein in endometrial epithelial cells of DES-treated mice was observed in this study. DES can induce cell transformation in the absence of detectable DNA damage (1) . Therefore, the results from the present study support the conclusion that cell cycle suppression by the p21 gene product may have occurred by a p53independent mechanism, with no marked DNA injury occurring in the target cells.
The results from the present study suggest that the transient cell cycle suppression and abnormal morphogenesis observed in the developing mouse endometrial epithelial cells following neonatal DES exposure is associated with, in part, the expression of the p21 gene product and the early and abnormal expression of the ERa and estrogen-regulated proteins (c-fos proto-oncogene product; lactoferrin).
